AnPac Bio Study Shows Strong Correlation between CDA Score and Risk of Cancer and Diseases Large Population Screening Study Reached Key Milestone with Over 2,000 Confirmed Cases Philadelphia, PA, October 4, 2021 – AnPac Bio-Medical Science Co., Ltd. (Nasdaq:ANPC, “AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United […]
Anpac Technology USA (Anpac Bio)
3 Spring House Innovation Park, Suite 150
Ambler, PA 19002
Email: [email protected]
Phone Number: +1 (267) 810-6776
Anpac Bio-Medical Science Co., Ltd.
Anpac Bio is a biotechnology company focusing on early cancer screening and detection and marketing a suite of cancer detection tests, including CDA (Cancer differentiation analysis), bio-chemistry, immunology, and genomics tests. Anpac has developed a multi-cancer screening and detection test that uses innovative, patented Cancer Differentiation Analysis (CDA) technology and proprietary cancer-detection device.